Your Location:
Home >
Browse articles >
Molecular Mechanism of Erzhiwan in Inhibiting Benign Prostatic Hyperplasia Base on Network Pharmacology
Molecular Mechanism of Erzhiwan in Inhibiting Benign Prostatic Hyperplasia Base on Network Pharmacology
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 25, Issue 5, Pages: 208-213(2019)
DOI: 10.13422/j.cnki.syfjx.20190508
Scan QR Code
Full Text(HTML)
Figs( 9 ) Tabs( 1 )
References
Publication Info
Metrics
120
Views
85
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Erzhiwan on Hepatocellular Carcinoma Based on Network Pharmacology
Molecular Mechanism of Ligustri Lucidi Fructus-Astragali Radix for Anti-cancer Based on Network Pharmacology
Comprehensive Evaluation of Quality of Erzhiwan Based on Five Characteristic Components
Network Prediction of Active Ingredient-target-pathway of Erzhiwan Against Liver Fibrosis
Material Basis of Entada phaseoloides Against Neuropathic Pain Based on in vitro Chemical Profiling and in vivo Absorbed Constituents
Related Author
Zhi-qiang CHEN
Yi CHEN
Zhe-xing MAI
Zhi-hua YANG
Chong ZHONG
Jing LI
Zhen-jie ZHUANG
Jia-rong LI
Related Institution
The First Clinical Medical College of Guangzhou University of Chinese Medicine
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
The First Affiliated Hospital of Hunan University of Chinese Medicine
Guangzhou University of Chinese Medicine
Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences


